From the firm’s Boston base, pharma research specialist Kristen Buteau and Brian Reese co-lead Choate, Hall & Stewart‘s patent prosecution group which is noted as making ’everything so easy for the client’. The team has a focus on life sciences-related work in particular; expert in the sector Brenda Herschbach Jarrell is a standout member of the cohort, who is highlighted as being ‘particularly creative with her IP solutions for many prosecution, diligence and other matters’. The ’truly exceptional’ Charles Lyon is equipped to assist investors and life sciences companies in their IP matters, while Stephanie Schonewald has particular expertise handling potentially contentious cases for biotech and pharma companies. Attorney John Rearick departed to Dechert LLP in July 2023.
Legal 500 redaktioneller Kommentar
- Profil
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
‘Brenda Herschbach Jarrell is particularly creative with her IP solutions for many prosecution, diligence and other matters.’
‘The stand-out partner is Brenda Herschbach Jarrell. She is extremely open, which we appreciate.'
'The Choate team makes everything so easy for their clients. Work product is always timely, and I trust its accuracy. They are great at making the answer very clear in their work product, and I don't have to spend hours poring over the work product in order to understand the key messages.'
'Charles Lyon is truly exceptional and I trust him implicitly.'
Kernmandanten
- BioNTech
- Carisma Therapeutics
- Radius Health
- Nextpoint Therapeutics
Anwält*innen
Führende Partner*innen
Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.
Praxisleitung
Kristen Buteau; Brian Reese
Weitere Kernanwält*innen
Brenda Herschbach Jarrell; Charles Lyon; Stephanie Schonewald